MariMed Inc.
MRMD
$0.1066
$0.00414.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 8.47% | 10.97% | 10.97% | 10.89% | 12.62% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.47% | 10.97% | 10.97% | 10.89% | 12.62% |
| Cost of Revenue | 11.43% | 15.13% | 13.93% | 18.02% | 23.67% |
| Gross Profit | 4.75% | 5.96% | 7.43% | 3.07% | 1.22% |
| SG&A Expenses | 23.14% | 28.48% | 28.95% | 19.26% | 9.91% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.82% | 20.08% | 19.39% | 18.49% | 18.13% |
| Operating Income | -51.94% | -49.84% | -39.51% | -29.30% | -18.61% |
| Income Before Tax | -278.70% | -190.84% | -159.74% | -133.81% | -66.96% |
| Income Tax Expenses | -46.10% | 52.86% | 82.10% | 59.67% | -54.17% |
| Earnings from Continuing Operations | -1,163.70% | -394.98% | -291.01% | -217.58% | -145.23% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -3,300.00% | -58.33% | 33.78% | 83.56% | 100.79% |
| Net Income | -1,171.74% | -396.84% | -293.21% | -219.03% | -150.29% |
| EBIT | -51.94% | -49.84% | -39.51% | -29.30% | -18.61% |
| EBITDA | -22.58% | -21.65% | -15.26% | -9.18% | -1.24% |
| EPS Basic | -1,780.00% | -366.09% | -274.90% | -207.77% | -131.75% |
| Normalized Basic EPS | -87.76% | -85.53% | -78.69% | -72.47% | -58.24% |
| EPS Diluted | -1,780.00% | -366.09% | -279.12% | -216.85% | -162.50% |
| Normalized Diluted EPS | -87.23% | -84.33% | -76.53% | -68.95% | -54.95% |
| Average Basic Shares Outstanding | 6.69% | 8.77% | 9.33% | 7.58% | 5.39% |
| Average Diluted Shares Outstanding | 3.59% | 2.51% | 0.01% | -4.49% | -0.91% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.93% | -1.19% | -1.30% | -1.48% | -2.14% |
